Risperidone versus olanzapine for treatment of schizophrenia

Schizophrenia Bulletin

Volumn 33, Issue 6, 2007, Pages 1274-1276

  Jayaram, Mahesh B ^a   Hosalli, Prakash M ^b   Stroup, Thomas S ^c  

^a Leeds Mental Health Trust   (United Kingdom)

^b Leeds Mental Health Foundation Trust   (United Kingdom)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Meta analysis; Olanzapine; Risperidone; Schizophrenia; Systematic review

Indexed keywords

OLANZAPINE; RISPERIDONE;

ANTICHOLINERGIC EFFECT; CALCULATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG INFORMATION; DRUG SAFETY; DRUG WITHDRAWAL; EJACULATION DISORDER; EXTRAPYRAMIDAL SYMPTOM; HOSPITAL READMISSION; HUMAN; INSOMNIA; MENTAL HEALTH; METABOLIC DISORDER; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; REGISTER; RELAPSE; RISK ASSESSMENT; SCHIZOPHRENIA; SHORT SURVEY; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; HUMANS; RISPERIDONE; SCHIZOPHRENIA;

EID: 35648983070     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbm101     Document Type: Short Survey

References (1)

1. Jayaram MB, Hosalli P, Stroup S. Risperidone versus olanzapine for schizophrenia. Cochrane Database Syst Rev. 2006;(2):CD005237.